S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Recent Reports Are A Wake-Up Call For Investors (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Recent Reports Are A Wake-Up Call For Investors (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Recent Reports Are A Wake-Up Call For Investors (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Recent Reports Are A Wake-Up Call For Investors (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary

Hippo Stock Price, News & Analysis (NYSE:HIPO)

$8.70
-0.03 (-0.34%)
(As of 12/7/2023 ET)
Compare
Today's Range
$8.39
$8.74
50-Day Range
$6.90
$9.78
52-Week Range
$6.64
$20.39
Volume
113,351 shs
Average Volume
101,641 shs
Market Capitalization
$207.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.33

Hippo MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
99.2% Upside
$17.33 Price Target
Short Interest
Healthy
8.04% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.11mentions of Hippo in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($11.90) to ($3.68) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.90 out of 5 stars

Finance Sector

431st out of 695 stocks

Fire, Marine, & Casualty Insurance Industry

25th out of 38 stocks


HIPO stock logo

About Hippo Stock (NYSE:HIPO)

Hippo Holdings Inc. provides home protection insurance in the United States and the District of Columbia. Its insurance products include homeowners' insurance against risks of fire, wind, and theft; and personal and commercial insurance products. The company distributes insurance products and services through its technology platform; and offers its policies online, over the phone, or through licensed insurance agents. It provides care and protection for homeowners, as well as operates an integrated home protection platform. The company is headquartered in Palo Alto, California.

HIPO Stock Price History

HIPO Stock News Headlines

Watch: Lion Messed with the Wrong Hippo
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Watch Enraged Hippo Attack Zookeeper
Rhinos and Hippos share points
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Animal protector killed by hippo
See More Headlines
Receive HIPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hippo and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/02/2023
Today
12/08/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/07/2024

Industry, Sector and Symbol

Industry
Fire, marine, & casualty insurance
Sub-Industry
N/A
Sector
Finance
Fax
N/A
Employees
590
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$17.33
High Stock Price Target
$25.00
Low Stock Price Target
$11.00
Potential Upside/Downside
+99.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$-333,400,000.00
Net Margins
-162.32%
Pretax Margin
-156.57%

Debt

Sales & Book Value

Annual Sales
$181 million
Book Value
$25.58 per share

Miscellaneous

Free Float
21,193,000
Market Cap
$207.82 million
Optionable
Optionable
Beta
1.20
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives















HIPO Stock Analysis - Frequently Asked Questions

Should I buy or sell Hippo stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hippo in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HIPO shares.
View HIPO analyst ratings
or view top-rated stocks.

What is Hippo's stock price target for 2024?

4 Wall Street analysts have issued 1-year target prices for Hippo's shares. Their HIPO share price targets range from $11.00 to $25.00. On average, they anticipate the company's share price to reach $17.33 in the next twelve months. This suggests a possible upside of 99.2% from the stock's current price.
View analysts price targets for HIPO
or view top-rated stocks among Wall Street analysts.

How have HIPO shares performed in 2023?

Hippo's stock was trading at $13.60 at the beginning of the year. Since then, HIPO stock has decreased by 36.0% and is now trading at $8.70.
View the best growth stocks for 2023 here
.

Are investors shorting Hippo?

Hippo saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 1,040,000 shares, a decrease of 6.3% from the October 31st total of 1,110,000 shares. Based on an average daily trading volume, of 121,700 shares, the days-to-cover ratio is currently 8.5 days. Currently, 8.0% of the shares of the stock are short sold.
View Hippo's Short Interest
.

When is Hippo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 7th 2024.
View our HIPO earnings forecast
.

How were Hippo's earnings last quarter?

Hippo Holdings Inc. (NYSE:HIPO) released its quarterly earnings data on Thursday, November, 2nd. The company reported ($2.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.66) by $0.42. The business earned $57.70 million during the quarter, compared to the consensus estimate of $56.80 million. Hippo had a negative net margin of 162.32% and a negative trailing twelve-month return on equity of 58.91%.

What ETFs hold Hippo's stock?

ETFs with the largest weight of Hippo (NYSE:HIPO) stock in their portfolio include Global X PropTech ETF (PTEC).

When did Hippo's stock split?

Hippo's stock reverse split on Friday, September 30th 2022. The 1-25 reverse split was announced on Friday, September 30th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 30th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Who are Hippo's major shareholders?

Hippo's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Charles Schwab Investment Management Inc. (0.46%), Ibex Investors LLC (0.37%), Sei Investments Co. (0.24%), Harel Insurance Investments & Financial Services Ltd. (0.24%), GSA Capital Partners LLP (0.20%) and Jacobs Levy Equity Management Inc. (0.16%). Insiders that own company stock include Assaf Wand, John Drake Nichols, Noah Knauf, Richard Mccathron and Sam Landman.
View institutional ownership trends
.

How do I buy shares of Hippo?

Shares of HIPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:HIPO) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -